Cell cycle inhibitors for the treatment of NSCLC.

about

The depletion of PinX1 involved in the tumorigenesis of non-small cell lung cancer promotes cell proliferation via p15/cyclin D1 pathway.Pharmacogenomics of Scopoletin in Tumor Cells.LncRNA BC032020 suppresses the survival of human pancreatic ductal adenocarcinoma cells by targeting ZNF451.

P2860

Q37736760-7C026E93-BDCE-4EBC-A411-8D89D62E6BD4 Q38777193-10740A8B-B84C-42B0-9767-1BD5569EF5D2 Q52726920-BB2F8685-D2D8-4F11-B7CC-7B9237930A3F

P2860

Cell cycle inhibitors for the treatment of NSCLC.

Item

http://www.wikidata.org/entity/Q38199197

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cell cycle inhibitors for the treatment of NSCLC.

@en

type

Item

label

Cell cycle inhibitors for the treatment of NSCLC.

@en

prefLabel

Cell cycle inhibitors for the treatment of NSCLC.

@en

P1476

Cell cycle inhibitors for the treatment of NSCLC.

@en

P2093

David Fernandes

http://www.w3.org/2001/XMLSchema#string

Haiying Cheng

http://www.w3.org/2001/XMLSchema#string

Marina Shcherba

http://www.w3.org/2001/XMLSchema#string

Roman Perez-Soler

http://www.w3.org/2001/XMLSchema#string

Yuanxin Liang

http://www.w3.org/2001/XMLSchema#string

P2860

A first-in-human, phase 1, dose-escalation study of dinaciclib, a novel cyclin-dependent kinase inhibitor, administered weekly in subjects with advanced malignancies

CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer

Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

The genetics of the p53 pathway, apoptosis and cancer therapy.

Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II

Role of cell cycle regulators in lung carcinogenesis

Polo-like kinases and the orchestration of cell division

P304

991-1004

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2014.902935

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24666387

http://www.w3.org/2001/XMLSchema#string

Cell cycle inhibitors for the treatment of NSCLC.

about

P2860

P2860

Cell cycle inhibitors for the treatment of NSCLC.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698